FindTrial
Sign In

Duct-to-mucosa and dunking methods of pancreaticojejunostomy after pancreaticoduodenectomy? A randomized clinical trial

Duct-to-mucosa and dunking methods of pancreaticojejunostomy after pancreaticoduodenectomy? A randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/000531
Enrollment
180
Registered
2010-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: pancreaticojeunostomy-dunking: nil Intervention2: pancreaticojejunostomy-duct to mucosa: nil Control Intervention1: NIL: NIL

Sponsors

aiims
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age of patient ≤ 70 years. b) Good performance status (ECOG 0, 1, 2) c) Patients with a diagnosis of i. Resectable periampullary carcinoma, duodenal tumor and small carcinoma of the head of pancreas ii. Neuroendocrine and others tumors in head of pancreas requiring pancreaticoduodenectomy iii. Chronic pancreatitis with suspicious mass in head of pancreas d) Patients who have given their informed consent

Exclusion criteria

Exclusion criteria: a. Metastatic disease b. Patient unwilling to consent for the study c. Pancreatic duct diameter <2 mm

Design outcomes

Primary

MeasureTime frame
To compare the duration, difficulty, and operative complications between the two techniques of pancreatic reconstructionTimepoint:—

Secondary

MeasureTime frame
To compare the postoperative outcome of the two proceduresTimepoint:—

Countries

India

Contacts

Public ContactDr Vivek Mangla
mangla.vivek@gmail.com01126593461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 26, 2026